J Neurosci 2007;27:10840-10848
For heart failure or CKD: Prioritize SGLT2i
Our White Plains medical team keeps a close eye on how your body is responding to your dose, and we adjust your plan accordingly to avoid the drawn, hollowed-out look that can come from aggressive weight loss
Busetto concludes: "In this analysis of individuals with obesity aged 65 years and older, semaglutide reduced body weight and improved cardiometabolic risk factors compared with placebo, and the safety and efficacy profile of semaglutide was consistent with that reported in the STEP program." He adds: "In many countries, including many high-income countries, the majority of the cases of excess weight actually occur in adults aged 65 years and over, representing a major driver for obesity-related complications and an important cause of reduced quality of life and disability
Information provided has been very much needed
Semaglutide's weight loss mechanisms work through appetite suppression and reduced caloric intake, not through caloric loss via diarrhea
